Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer
To compare the value of dynamic contrast-enhanced magnetic resonance imaging-pharmacokinetic (PK) parameters vs tumor volume in predicting breast cancer neoadjuvant chemotherapy response (NACR) and patient survival.
Source: Current Problems in Diagnostic Radiology - Category: Radiology Authors: Basak E. Dogan, Qing Yuan, Roland Bassett, Inanc Guvenc, Edward F. Jackson, Massimo Cristofanilli, Gary J. Whitman Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology